Percutaneous Full Endoscopic Interlaminar Decompression Combined with Percutaneous Vertebroplasty in Treatment of Thoracic Vertebral Tumors.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
6 patients with thoracic vertebral tumors (from T5 to T12) underwent PEID.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Mean surgical time was 101 ± 18 minutes. [CONCLUSIONS] In this study, we defined a full endoscopic interlaminar separation technique, PEID, that we applied in combination with vertebroplasty in patients with tumors in the thoracic vertebra levels.
[OBJECTIVE] Separation surgery is a good alternative as a minimally invasive procedure in the treatment of oncological disease.
APA
Çeliker Ö, Kocaoğlu M (2026). Percutaneous Full Endoscopic Interlaminar Decompression Combined with Percutaneous Vertebroplasty in Treatment of Thoracic Vertebral Tumors.. World neurosurgery, 205, 124703. https://doi.org/10.1016/j.wneu.2025.124703
MLA
Çeliker Ö, et al.. "Percutaneous Full Endoscopic Interlaminar Decompression Combined with Percutaneous Vertebroplasty in Treatment of Thoracic Vertebral Tumors.." World neurosurgery, vol. 205, 2026, pp. 124703.
PMID
41344395 ↗
Abstract 한글 요약
[OBJECTIVE] Separation surgery is a good alternative as a minimally invasive procedure in the treatment of oncological disease. We applied percutaneous full endoscopic interlaminar decompression (PEID) with vertebroplasty in treatment of thoracic tumors to avoid the morbidity associated with conventional approaches.
[METHODS] Between May 2023 and June 2025, 6 patients with thoracic vertebral tumors (from T5 to T12) underwent PEID. The patients were administered general anesthesia and positioned in the prone position. PEID with vertebroplasty was performed using the interlaminar approach.
[RESULTS] The patients included 3 women and 3 men with a mean age of 53.3 ± 9.7 years (range, 44-66 years). There were improvements in cord compression findings, and mean visual analog scale scores improved from 6.5 ± 1 preoperatively to 3.5 ± 1.1 postoperatively. Pathology showed lymphoma in 2 patients, metastasis in 2 patients, cavernous hemangioma in 1 patient, and plasmacytoma in 1 patient. Mean surgical time was 101 ± 18 minutes.
[CONCLUSIONS] In this study, we defined a full endoscopic interlaminar separation technique, PEID, that we applied in combination with vertebroplasty in patients with tumors in the thoracic vertebra levels.
[METHODS] Between May 2023 and June 2025, 6 patients with thoracic vertebral tumors (from T5 to T12) underwent PEID. The patients were administered general anesthesia and positioned in the prone position. PEID with vertebroplasty was performed using the interlaminar approach.
[RESULTS] The patients included 3 women and 3 men with a mean age of 53.3 ± 9.7 years (range, 44-66 years). There were improvements in cord compression findings, and mean visual analog scale scores improved from 6.5 ± 1 preoperatively to 3.5 ± 1.1 postoperatively. Pathology showed lymphoma in 2 patients, metastasis in 2 patients, cavernous hemangioma in 1 patient, and plasmacytoma in 1 patient. Mean surgical time was 101 ± 18 minutes.
[CONCLUSIONS] In this study, we defined a full endoscopic interlaminar separation technique, PEID, that we applied in combination with vertebroplasty in patients with tumors in the thoracic vertebra levels.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.